Surgery Partners, Inc. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
Surgery Partners, Inc. (SGRY) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $28.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-08-10
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $28.50M, a 29.98% decline year-over-year.
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was -$1.70M.
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was $18.90M, a 530.00% increase year-over-year.
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-06-30 was $40.70M, a 103.50% increase year-over-year.
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was $81.70M.
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was -$24.30M, a 124.92% decline from fiscal 2023.
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was $97.50M, a 129.41% increase from fiscal 2022.
- Surgery Partners, Inc. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $42.50M, a 94.95% increase from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 1 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 4 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 4 month as first filed | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 8 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.50M 10-Q · filed 2026-08-10 | $26.80M derived: sum of 2 quarters · filed 2026-08-10 | ||||||||
| 2026-03-31 | -$1.70M 10-Q · filed 2026-08-10 | |||||||||
| 2025-12-31 | $81.70M 10-K · filed 2026-03-02 | |||||||||
| 2025-09-30 | $18.90M 10-Q · filed 2025-11-10 | $59.60M derived: sum of 2 quarters · filed 2026-08-10 | $54.50M derived: sum of 3 quarters · filed 2026-08-10 | |||||||
| 2025-06-30 | $40.70M 10-Q · filed 2026-08-10 | $35.60M derived: sum of 2 quarters · filed 2026-08-10 | ||||||||
| 2025-03-31 | -$5.10M 10-Q · filed 2026-08-10 | |||||||||
| 2024-12-31 | -$24.30M 10-K · filed 2026-03-02 | |||||||||
| 2024-09-30 | $3.00M 10-Q · filed 2025-11-10 | $23.00M derived: sum of 2 quarters · filed 2025-11-10 | $39.90M derived: sum of 3 quarters · filed 2025-11-10 | |||||||
| 2024-06-30 | $20.00M 10-Q · filed 2025-11-10 | $36.90M derived: sum of 2 quarters · filed 2025-11-10 | ||||||||
| 2024-03-31 | $16.90M 10-Q · filed 2025-11-10 | |||||||||
| 2023-12-31 | $97.50M 10-K · filed 2026-03-02 | |||||||||
| 2023-09-30 | $23.10M 10-Q · filed 2024-11-12 | $69.70M derived: sum of 2 quarters · filed 2024-11-12 | $63.00M derived: sum of 3 quarters · filed 2024-11-12 | |||||||
| 2023-06-30 | $46.60M 10-Q · filed 2024-11-12 | $39.90M derived: sum of 2 quarters · filed 2024-11-12 | ||||||||
| 2023-03-31 | -$6.70M 10-Q · filed 2024-11-12 | |||||||||
| 2022-12-31 | $42.50M 10-K · filed 2025-03-07 | |||||||||
| 2022-09-30 | -$2.70M 10-Q · filed 2023-11-07 | $1.60M derived: sum of 2 quarters · filed 2023-11-07 | $33.80M derived: sum of 3 quarters · filed 2023-11-07 | |||||||
| 2022-06-30 | $4.30M 10-Q · filed 2023-11-07 | $36.50M derived: sum of 2 quarters · filed 2023-11-07 | ||||||||
| 2022-03-31 | $32.20M 10-Q · filed 2023-11-07 | |||||||||
| 2021-12-31 | $21.80M 10-K · filed 2024-02-26 | |||||||||
| 2021-09-30 | -$1.20M 10-Q · filed 2022-11-08 | -$6.10M derived: sum of 2 quarters · filed 2022-11-08 | -$6.00M derived: sum of 3 quarters · filed 2022-11-08 | |||||||
| 2021-06-30 | -$4.90M 10-Q · filed 2022-11-08 | -$4.80M derived: sum of 2 quarters · filed 2022-11-08 | ||||||||
| 2021-03-31 | $100.00K 10-Q · filed 2022-11-08 | |||||||||
| 2020-12-31 | -$30.40M 10-K · filed 2023-03-01 | |||||||||
| 2020-09-30 | -$42.30M 10-Q · filed 2021-11-03 | -$52.00M derived: sum of 2 quarters · filed 2021-11-03 | -$65.90M derived: sum of 3 quarters · filed 2021-11-03 | |||||||
| 2020-06-30 | -$9.70M 10-Q · filed 2021-11-03 | -$23.60M derived: sum of 2 quarters · filed 2021-11-03 | ||||||||
| 2020-03-31 | -$13.90M 10-Q · filed 2021-11-03 | |||||||||
| 2019-12-31 | $6.00M 10-K · filed 2022-03-01 | |||||||||
| 2019-09-30 | $3.60M 10-Q · filed 2020-11-04 | $2.50M derived: sum of 2 quarters · filed 2020-11-04 | -$1.60M derived: sum of 3 quarters · filed 2020-11-04 | -$122.73M derived: sum of 4 quarters · filed 2021-03-10 | ||||||
| 2019-06-30 | -$1.10M 10-Q · filed 2020-11-04 | -$5.20M derived: sum of 2 quarters · filed 2020-11-04 | -$126.33M derived: sum of 3 quarters · filed 2021-03-10 | -$130.93M derived: sum of 4 quarters · filed 2021-03-10 | ||||||
| 2019-03-31 | -$4.10M 10-Q · filed 2020-11-04 | -$125.23M derived: sum of 2 quarters · filed 2021-03-10 | -$129.83M derived: sum of 3 quarters · filed 2021-03-10 | -$132.73M derived: sum of 4 quarters · filed 2021-03-10 | ||||||
| 2018-12-31 | -$121.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$125.73M derived: sum of 2 quarters · filed 2021-03-10 | -$128.63M derived: sum of 3 quarters · filed 2021-03-10 | -$130.20M 10-K · filed 2021-03-10 | -$130.17M 10-K · filed 2019-03-15 | |||||
| 2018-09-30 | -$4.60M 10-Q · filed 2019-11-06 | -$7.50M derived: sum of 2 quarters · filed 2019-11-06 | -$9.07M 10-Q · filed 2018-11-09 | |||||||
| 2018-06-30 | -$2.90M 10-Q · filed 2019-11-06 | -$4.46M 10-Q · filed 2018-08-09 | ||||||||
| 2018-03-31 | -$1.60M 10-Q · filed 2019-11-06 | -$1.61M 10-Q · filed 2018-05-10 | ||||||||
| 2017-12-31 | -$14.60M 10-K · filed 2020-03-13 | -$14.61M 10-K · filed 2018-03-16 | ||||||||
| 2017-09-30 | -$3.70M 10-Q · filed 2017-11-09 | |||||||||
| 2017-08-31 | $20.80M 10-K · filed 2020-03-13 | |||||||||
| 2017-06-30 | $8.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $18.94M 10-Q · filed 2017-08-09 | $52.06M derived: sum of 3 quarters · filed 2017-08-09 | $62.54M derived: sum of 4 quarters · filed 2017-08-09 | ||||||
| 2017-03-31 | $10.64M 10-Q · filed 2017-05-10 | $43.76M derived: sum of 2 quarters · filed 2017-05-10 | $54.23M derived: sum of 3 quarters · filed 2017-05-10 | $71.69M derived: sum of 4 quarters · filed 2017-05-10 | ||||||
| 2016-12-31 | $33.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $43.60M derived: sum of 2 quarters · filed 2017-03-10 | $61.06M derived: sum of 3 quarters · filed 2017-03-10 | $67.06M 10-K · filed 2017-03-10 | ||||||
| 2016-09-30 | $10.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $27.93M derived: sum of 2 quarters · filed 2016-11-10 | $33.94M 10-Q · filed 2016-11-10 | $65.14M derived: sum of 4 quarters · filed 2017-03-10 | ||||||
| 2016-06-30 | $17.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $23.46M 10-Q · filed 2016-08-10 | $54.67M derived: sum of 3 quarters · filed 2017-03-10 | |||||||
| 2016-03-31 | $6.00M 10-Q · filed 2016-05-06 | $37.21M derived: sum of 2 quarters · filed 2017-03-10 | ||||||||
| 2015-12-31 | $31.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $55.23M 10-K · filed 2017-03-10 | ||||||||
| 2015-09-30 | $24.02M 10-Q · filed 2015-11-13 | |||||||||
| 2014-12-31 | -$31.13M 10-K · filed 2017-03-10 | |||||||||
| 2013-12-31 | $17.73M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |